4//SEC Filing
Dudley Robert E. 4
Accession 0001213900-21-047810
CIK 0001817944other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:31 PM ET
Size
5.2 KB
Accession
0001213900-21-047810
Insider Transaction Report
Form 4
Dudley Robert E.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-09-09+4,566→ 4,566 total
Footnotes (1)
- [F1]Received pursuant to the Agreement and Plan of Merger, dated as of April 27, 2021 by and among Blue Water Acquisition Corp. (n/k/a Clarus Therapeutics Holdings, Inc.) (the "Issuer"), Blue Water Merger Sub Corp. and Clarus Therapeutics, Inc. ("Legacy Clarus") (the "Merger Agreement") pursuant to which, through a merger, Legacy Clarus became a direct, wholly-owned subsidiary of the Issuer.
Documents
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeother
Related Parties
1- filerCIK 0001510208
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 8:31 PM ET
- Size
- 5.2 KB